BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36718943)

  • 1. An intellectual disability-related MED23 mutation dysregulates gene expression by altering chromatin conformation and enhancer activities.
    Yang Y; Li C; Chen Z; Zhang Y; Tian Q; Sun M; Zhang S; Yu M; Wang G
    Nucleic Acids Res; 2023 Mar; 51(5):2137-2150. PubMed ID: 36718943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MED23 mutation links intellectual disability to dysregulation of immediate early gene expression.
    Hashimoto S; Boissel S; Zarhrate M; Rio M; Munnich A; Egly JM; Colleaux L
    Science; 2011 Aug; 333(6046):1161-3. PubMed ID: 21868677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MED23-associated intellectual disability in a non-consanguineous family.
    Trehan A; Brady JM; Maduro V; Bone WP; Huang Y; Golas GA; Kane MS; Lee PR; Thurm A; Gropman AL; Paul SM; Vezina G; Markello TC; Gahl WA; Boerkoel CF; Tifft CJ
    Am J Med Genet A; 2015 Jun; 167(6):1374-80. PubMed ID: 25845469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Mediator subunit MED23 couples H2B mono-ubiquitination to transcriptional control and cell fate determination.
    Yao X; Tang Z; Fu X; Yin J; Liang Y; Li C; Li H; Tian Q; Roeder RG; Wang G
    EMBO J; 2015 Dec; 34(23):2885-902. PubMed ID: 26330467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediator MED23 regulates basal transcription in vivo via an interaction with P-TEFb.
    Wang W; Yao X; Huang Y; Hu X; Liu R; Hou D; Chen R; Wang G
    Transcription; 2013; 4(1):39-51. PubMed ID: 23340209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective requirement for Mediator MED23 in Ras-active lung cancer.
    Yang X; Zhao M; Xia M; Liu Y; Yan J; Ji H; Wang G
    Proc Natl Acad Sci U S A; 2012 Oct; 109(41):E2813-22. PubMed ID: 22988093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediator MED23 Links Pigmentation and DNA Repair through the Transcription Factor MITF.
    Xia M; Chen K; Yao X; Xu Y; Yao J; Yan J; Shao Z; Wang G
    Cell Rep; 2017 Aug; 20(8):1794-1804. PubMed ID: 28834744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediator MED23 plays opposing roles in directing smooth muscle cell and adipocyte differentiation.
    Yin JW; Liang Y; Park JY; Chen D; Yao X; Xiao Q; Liu Z; Jiang B; Fu Y; Bao M; Huang Y; Liu Y; Yan J; Zhu MS; Yang Z; Gao P; Tian B; Li D; Wang G
    Genes Dev; 2012 Oct; 26(19):2192-205. PubMed ID: 22972934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediator Med23 deficiency enhances neural differentiation of murine embryonic stem cells through modulating BMP signaling.
    Zhu W; Yao X; Liang Y; Liang D; Song L; Jing N; Li J; Wang G
    Development; 2015 Feb; 142(3):465-76. PubMed ID: 25564654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction to 'An intellectual disability-related MED23 mutation dysregulates gene expression by altering chromatin conformation and enhancer activities'.
    Nucleic Acids Res; 2023 Mar; 51(5):2499. PubMed ID: 36806874
    [No Abstract]   [Full Text] [Related]  

  • 11. T-cells null for the MED23 subunit of mediator express decreased levels of KLF2 and inefficiently populate the peripheral lymphoid organs.
    Kasper LH; Fukuyama T; Brindle PK
    PLoS One; 2014; 9(7):e102076. PubMed ID: 25054639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Mediator Med23 controls a transcriptional switch for muscle stem cell proliferation and differentiation in muscle regeneration.
    Fang Y; Yuan C; Li C; Lu C; Yu W; Wang G
    Cell Rep; 2024 May; 43(5):114177. PubMed ID: 38691453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MED12-related XLID disorders are dose-dependent of immediate early genes (IEGs) expression.
    Donnio LM; Bidon B; Hashimoto S; May M; Epanchintsev A; Ryan C; Allen W; Hackett A; Gecz J; Skinner C; Stevenson RE; de Brouwer APM; Coutton C; Francannet C; Jouk PS; Schwartz CE; Egly JM
    Hum Mol Genet; 2017 Jun; 26(11):2062-2075. PubMed ID: 28369444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Med23 supports angiogenesis and maintains vascular integrity through negative regulation of angiopoietin2 expression.
    Yang Y; Xiao Q; Yin J; Li C; Yu D; He Y; Yang Z; Wang G
    Commun Biol; 2022 Apr; 5(1):374. PubMed ID: 35440711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediator MED23 links insulin signaling to the adipogenesis transcription cascade.
    Wang W; Huang L; Huang Y; Yin JW; Berk AJ; Friedman JM; Wang G
    Dev Cell; 2009 May; 16(5):764-71. PubMed ID: 19460352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediator MED23 cooperates with RUNX2 to drive osteoblast differentiation and bone development.
    Liu Z; Yao X; Yan G; Xu Y; Yan J; Zou W; Wang G
    Nat Commun; 2016 Apr; 7():11149. PubMed ID: 27033977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus L-E1A activates transcription through mediator complex-dependent recruitment of the super elongation complex.
    Vijayalingam S; Chinnadurai G
    J Virol; 2013 Mar; 87(6):3425-34. PubMed ID: 23302885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver Med23 ablation improves glucose and lipid metabolism through modulating FOXO1 activity.
    Chu Y; Gómez Rosso L; Huang P; Wang Z; Xu Y; Yao X; Bao M; Yan J; Song H; Wang G
    Cell Res; 2014 Oct; 24(10):1250-65. PubMed ID: 25223702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of MED23 promoted the tumorigenecity of esophageal squamous cell carcinoma.
    Shi J; Han Q; Zhao H; Zhong C; Yao F
    Mol Carcinog; 2014 Oct; 53(10):833-40. PubMed ID: 23625751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of mediator MED23 in non-small-cell lung cancer promotes the growth, migration, and metastasis of cancer cells.
    Shi J; Liu H; Yao F; Zhong C; Zhao H
    Tumour Biol; 2014 Dec; 35(12):12005-13. PubMed ID: 25273169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.